Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optical biosensor assay (OBA).

Y G Tsay1, C I Lin, J Lee

  • 1Adeza Biomedical Corp., Sunnyvale, CA 94089.

Clinical Chemistry
|September 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Subsolar-Mass Binaries in the First Half of Advanced LIGO's and Advanced Virgo's Third Observing Run.

Physical review letters·2022
Same author

Point Absorber Limits to Future Gravitational-Wave Detectors.

Physical review letters·2021
Same author

Constraints on Cosmic Strings Using Data from the Third Advanced LIGO-Virgo Observing Run.

Physical review letters·2021
Same author

Approaching the motional ground state of a 10-kg object.

Science (New York, N.Y.)·2021
Same author

Prospects for observing and localizing gravitational-wave transients with Advanced LIGO, Advanced Virgo and KAGRA.

Living reviews in relativity·2020
Same author

GW190521: A Binary Black Hole Merger with a Total Mass of 150  M_{⊙}.

Physical review letters·2020

A novel biosensor immunoassay uses optical diffraction to detect analytes in body fluids. This method quantifies choriogonadotropin in serum, enabling precise diagnostics.

Area of Science:

  • Biomedical Engineering
  • Analytical Chemistry
  • Immunotechnology

Background:

  • Accurate detection of clinical analytes in human body fluids is crucial for disease diagnosis and monitoring.
  • Existing immunoassay techniques may require complex procedures or expensive equipment.
  • Development of sensitive and quantitative biosensors is an ongoing area of research.

Purpose of the Study:

  • To introduce a new biosensor immunoassay that utilizes optical diffraction for analyte detection.
  • To demonstrate the capability of this biosensor for quantitative analysis of clinically relevant biomarkers.
  • To validate the assay's performance using a specific example, choriogonadotropin in serum.

Main Methods:

  • A silicon wafer serves as a substrate for immobilizing antigens or antibodies.

Related Experiment Videos

  • Photo mask illumination creates patterned active and inactive protein areas on the wafer surface.
  • Antigen-antibody binding in positive samples forms a biological diffraction grating.
  • Laser illumination of the grating produces a measurable diffraction signal.

    • Main Results:

    • The biosensor successfully differentiates between positive and negative samples based on the presence or absence of a diffraction signal.
    • The intensity of the diffracted light correlates quantitatively with the analyte concentration.
    • The assay demonstrated effective quantitative detection of choriogonadotropin in human serum samples.

    Conclusions:

    • The described optical diffraction biosensor immunoassay offers a novel and sensitive method for detecting and quantifying analytes in biological samples.
    • This technique has the potential for widespread application in clinical diagnostics due to its simplicity and quantitative capabilities.
    • Further development could lead to rapid, point-of-care diagnostic tools based on this principle.